Product
MydCombi
Aliases
tropicamide and phenylephrine hydrochloride ophthalmic spray 1%/2.5%
Name
Tropicamide
INN Name
Tropicamide
FDA Approved
Yes
2 clinical trials
6 organizations
3 indications
3 documents
Indication
MydriasisIndication
DilationIndication
Absence of Pupil ReactionClinical trial
A Single-Center, Open Label, Phase 4 Study of the Safety and Efficacy of Fixed Combination Phenylephrine 2.5%-Tropicamide 1% Ophthalmic Solution (Mydcombi®) Administered With the Mydcombi Dispenser for Pupil Dilation (THE MIST-2.1 STUDY)Status: Completed, Estimated PCD: 2024-01-09
Clinical trial
Efficacy of the MydCombi on Pupillary Dilation in Pediatric and Adult PatientsStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Organization
Somerset Therapeutics, LLCDocument
DailyMed Label: MYDCOMBIOrganization
Eyenovia, Inc.Organization
Akorn - Strides LLC Document
DailyMed Label: Mydriacyl Organization
Alcon Laboratories, Inc.Document
DailyMed Label: TropicamideOrganization
Sandoz Inc. Organization
BAUSCH & LOMB INCORPORATED